PATH vs. DOCU, ESTC, DUOL, GEN, PCOR, CFLT, SPSC, KVYO, BRZE, and CXM
Should you be buying UiPath stock or one of its competitors? The main competitors of UiPath include DocuSign (DOCU), Elastic (ESTC), Duolingo (DUOL), Gen Digital (GEN), Procore Technologies (PCOR), Confluent (CFLT), SPS Commerce (SPSC), Klaviyo (KVYO), Braze (BRZE), and Sprinklr (CXM). These companies are all part of the "prepackaged software" industry.
UiPath (NYSE:PATH) and DocuSign (NASDAQ:DOCU) are both large-cap business services companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, community ranking, earnings and risk.
UiPath has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, DocuSign has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500.
DocuSign has higher revenue and earnings than UiPath. UiPath is trading at a lower price-to-earnings ratio than DocuSign, indicating that it is currently the more affordable of the two stocks.
In the previous week, UiPath had 7 more articles in the media than DocuSign. MarketBeat recorded 18 mentions for UiPath and 11 mentions for DocuSign. UiPath's average media sentiment score of 0.69 beat DocuSign's score of 0.64 indicating that UiPath is being referred to more favorably in the media.
DocuSign received 287 more outperform votes than UiPath when rated by MarketBeat users. Likewise, 59.71% of users gave DocuSign an outperform vote while only 45.13% of users gave UiPath an outperform vote.
62.5% of UiPath shares are owned by institutional investors. Comparatively, 77.6% of DocuSign shares are owned by institutional investors. 31.0% of UiPath shares are owned by insiders. Comparatively, 1.7% of DocuSign shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
DocuSign has a net margin of 2.68% compared to UiPath's net margin of -6.87%. DocuSign's return on equity of 13.91% beat UiPath's return on equity.
UiPath currently has a consensus target price of $27.41, indicating a potential upside of 40.21%. DocuSign has a consensus target price of $60.25, indicating a potential upside of 2.43%. Given UiPath's stronger consensus rating and higher possible upside, analysts plainly believe UiPath is more favorable than DocuSign.
Summary
DocuSign beats UiPath on 10 of the 18 factors compared between the two stocks.
Get UiPath News Delivered to You Automatically
Sign up to receive the latest news and ratings for PATH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PATH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
